Brief: China Regenerative Medicine International re-designates Ray Yip to an executive director
08/09/2017 14:37
Sept 8 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* Ray Yip will be re-designated from a non-executive
director to an executive director
* Shao Zhengkang has tendered his resignation to act as an
executive director
Source text for Eikon: urn:newsml:reuters.com:*:nHKSbrlz1D
Further company coverage: 8158.HK
(bangalore.newsroom@thomsonreuters.com)
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital